Drawing for CARDINAL

USPTO serial 85245234

CARDINAL

Reviewed by CopyMark Law Group

Status 605
Filing date
Status date
Registration date
—
Examiner
MARTIN, JENNIFER MCGARRY
Law office
OFFICE OF TRADEMARK PROGRAM CONTROL

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with CARDINAL?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Lawrence E. Abelman

LAWRENCE E. ABELMAN ABELMAN, FRAYNE & SCHWAB666 3RD AVENEW YORK, NY 10017-4011UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
010Medical devices, namely, annuloplasty ringsABANDONED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 31, 2011MAB5ABANDONMENT NOTICE MAILED - AFTER PUBLICATION—
Oct 31, 2011ABN5ABANDONMENT - AFTER PUBLICATION—
Oct 18, 2011EXARTEAS EXPRESS ABANDONMENT RECEIVED—
Jul 28, 2011ETOFEXTENSION OF TIME TO OPPOSE RECEIVED—
Jun 28, 2011PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jun 8, 2011NPUBNOTICE OF PUBLICATION—
May 20, 2011CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
May 18, 2011DOCKASSIGNED TO EXAMINER—
Feb 23, 2011NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Feb 21, 2011NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance